Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
PTCT	PTC THERAPEUTICS INC	United States	$2.54B	76,696,785	85.81%	14.19%	Net Selling	Net Selling
OMER	OMEROS CORP	United States	$199.91M	57,944,159	43.86%	6.69%	Net Buying
PMD	PSYCHEMEDICS CORP	United States	$14.98M	5,805,611	20.81%	49.61%	Net Selling
ADXN	ADDEX THERAPEUTICS LTD	Switzerland	$8.80M	125,195,393	0.00%	0.00%
OMI	OWENS & MINOR INC	United States	$1.42B	76,499,288	93.02%	6.98%	Net Selling	Net Selling
INBX	INHIBRX INC	United States	$1.82B	52,401,941	71.38%	28.62%	Net Buying
SNOA	SONOMA PHARMACEUTICALS INC	United States	$3.68M	15,607,433	1.05%	24.91%
SMMT	SUMMIT THERAPEUTICS INC	United Kingdom	$3.12B	701,979,596	7.06%	92.92%	Net Buying	Net Buying
AVTX	AVALO THERAPEUTICS INC	United States	$9.92M	1,034,130	0.11%	99.89%	Net Selling
IKT	INHIBIKASE THERAPEUTICS INC	United States	$11.20M	6,476,844	3.17%	84.17%
KZIA	KAZIA THERAPEUTICS LTD	Australia	$7.43M	263,615,444	0.14%	8.44%
EYEN	EYENOVIA INC	United States	$40.40M	53,870,762	14.64%	24.20%	Net Buying	Net Buying
MODV	MODIVCARE INC	United States	$390.94M	14,210,882	39.01%	60.99%	Net Buying	Net Buying
AHCO	ADAPTHEALTH CORP	United States	$1.33B	133,201,924	45.59%	54.41%	Net Selling	Net Selling
TRIB	TRINITY BIOTECH PLC	Ireland	$12.11M	153,310,284	1.91%	0.00%
TRVN	TREVENA INC	United States	$7.43M	18,340,953	11.24%	88.76%	Net Buying
NVOS	NOVO INTEGRATED SCIENCES INC	United States	$9.15M	19,054,523	4.22%	95.78%
CGC	CANOPY GROWTH CORP	Canada	$988.59M	91,114,604	7.44%	92.56%	Net Selling
EVAX	EVAXION BIOTECH A	Denmark	$14.10M	37,897,780	1.01%	0.00%
CSBR	CHAMPIONS ONCOLOGY INC	United States	$63.89M	13,593,767	1.91%	98.09%	Net Buying
SNDA	SONIDA SENIOR LIVING INC	United States	$448.33M	13,854,520	17.03%	82.97%	Net Buying	Net Buying
TIVC	TIVIC HEALTH SYSTEMS INC	United States	$2.91M	6,183,592	1.09%	42.92%
OWLT	OWLET INC	United States	$35.74M	9,047,883	6.22%	93.78%	Net Selling	Net Selling
TLSA	TIZIANA LIFE SCIENCES LTD	United Kingdom	$76.70M	103,087,744	0.79%	0.00%
TOVX	THERIVA BIOLOGICS INC	United States	$6.41M	17,277,371	4.58%	1.45%	Net Buying
PHGE	BIOMX INC	United States	$18.72M	55,220,077	24.98%	56.80%	Net Buying	Net Buying
FOXO	FOXO TECHNOLOGIES INC	United States	$2.66M	8,946,032	1.33%	98.67%	Net Selling
ACON	ACLARION INC	United States	$2.67M	8,203,500	1.92%	17.27%
PRFX	PAINREFORM LTD	Israel	$1.57M	1,850,243	9.63%	0.00%
GLPG	GALAPAGOS NV	Belgium	$1.95B	65,897,071	30.89%	0.00%
BIVI	BIOVIE INC	United States	$30.02M	61,018,606	10.97%	78.86%	Net Selling
VSTM	VERASTEM INC	United States	$291.24M	25,325,551	25.63%	74.37%	Net Selling	Net Selling
UNCY	UNICYCIVE THERAPEUTICS INC	United States	$39.11M	37,606,630	56.43%	16.64%
SAVA	CASSAVA SCIENCES INC	United States	$1.11B	47,976,166	23.75%	73.20%	Net Buying	Net Buying
QTI	QT IMAGING HOLDINGS INC	United States	$19.08M	21,441,416	4.94%	95.06%	Net Buying	Net Buying
BDSX	BIODESIX INC	United States	$180.63M	114,685,783	13.96%	61.11%	Net Buying	Net Selling
BCAB	BIOATLA INC	United States	$136.17M	48,115,918	51.62%	33.67%	Net Buying	Net Selling
NVST	ENVISTA HOLDINGS CORP	United States	$3.18B	171,858,245	62.86%	37.14%	Net Selling	Net Selling
NRXS	NEURAXIS INC	United States	$20.05M	6,594,897	1.13%	39.99%	Net Buying
CCM	CONCORD MEDICAL SERVICES HOLDINGS LTD	China	$21.82M	130,251,685	0.04%	0.00%
NCNA	NUCANA PLC	United Kingdom	$8.09M	56,660,000	16.42%	0.00%
INAB	IN8BIO INC	United States	$45.45M	44,123,949	19.55%	51.06%	Net Buying
ATXI	AVENUE THERAPEUTICS INC	United States	$3.51M	940,986	14.17%	85.83%	Net Buying
PSTV	PLUS THERAPEUTICS INC	United States	$12.78M	5,704,219	0.43%	99.57%	Net Buying	Net Buying
MREO	MEREO BIOPHARMA GROUP PLC	United Kingdom	$448.87M	701,363,484	11.98%	4.58%
NXL	NEXALIN TECHNOLOGY INC	United States	$9.74M	7,436,562	0.85%	32.87%
EVO	EVOTEC SE	Germany	$1.86B	177,185,736	2.79%	0.00%
MGX	METAGENOMI INC	United States	$262.25M	37,464,201	33.76%	32.96%	Net Buying
MGRX	MANGOCEUTICALS INC	United States	$5.98M	24,819,500	1.32%	39.08%
BHVN	BIOHAVEN LTD	United States	$3.30B	88,291,909	79.48%	20.52%	Net Buying	Net Buying
MLEC	MOOLEC SCIENCE SA	Luxembourg	$45.08M	37,563,768	0.26%	9.18%
CING	CINGULATE INC	United States	$4.85M	6,046,479	1.55%	98.45%	Net Buying	Net Buying
ZTEK	ZENTEK LTD	Canada	$115.99M	100,859,577	0.93%	0.00%
GCTK	GLUCOTRACK INC	United States	$13.70M	27,393,002	2.86%	12.28%	Net Buying	Net Buying
NERV	MINERVA NEUROSCIENCES INC	United States	$17.62M	6,993,406	5.94%	94.06%
FNCH	FINCH THERAPEUTICS GROUP INC	United States	$3.12M	1,605,763	0.73%	99.27%	Net Selling	Net Selling
EPRX	EUPRAXIA PHARMACEUTICALS INC	Canada	$104.73M	35,622,553	0.00%	0.00%
ANEB	ANEBULO PHARMACEUTICALS INC	United States	$59.65M	25,933,217	24.91%	75.09%
ANGO	ANGIODYNAMICS INC	United States	$241.93M	40,054,533	79.66%	20.34%	Net Selling	Net Buying
GUTS	FRACTYL HEALTH INC	United States	$338.15M	47,896,908	46.61%	53.39%	Net Buying
ALVO	ALVOTECH	Luxembourg	$3.60B	266,821,844	5.34%	0.00%
APVO	APTEVO THERAPEUTICS INC	United States	$3.26M	4,080,169	0.06%	91.99%
BEAT	HEARTBEAM INC	United States	$54.50M	26,329,032	7.60%	22.24%	Net Selling
IRIX	IRIDEX CORP	United States	$43.23M	16,252,948	14.73%	85.27%	Net Buying
ACXP	ACURX PHARMACEUTICALS INC	United States	$35.65M	15,843,102	7.88%	15.18%	Net Buying
CTCX	CARMELL CORP	United States	$42.65M	20,803,228	11.04%	54.68%	Net Buying
ELUT	ELUTIA INC	United States	$80.60M	24,349,914	16.31%	83.69%	Net Selling	Net Selling
INTS	INTENSITY THERAPEUTICS INC	United States	$67.05M	13,711,877	11.91%	14.62%
CVM	CEL SCI CORP	United States	$68.78M	54,159,937	13.79%	40.64%	Net Buying	Net Buying
SSKN	STRATA SKIN SCIENCES INC	United States	$13.81M	35,060,920	9.58%	90.42%	Net Buying
IXHL	INCANNEX HEALTHCARE INC	Australia	$39.68M	15,873,113	3.97%	27.69%
GANX	GAIN THERAPEUTICS INC	United States	$47.48M	18,051,979	10.34%	1.89%	Net Buying	Net Buying
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	United States	$12.99M	37,118,593	12.69%	39.87%	Net Buying
STRM	STREAMLINE HEALTH SOLUTIONS INC	United States	$20.65M	65,362,533	18.80%	81.05%	Net Buying	Net Buying
SLS	SELLAS LIFE SCIENCES GROUP INC	United States	$84.32M	57,754,928	13.29%	13.12%	Net Selling
TAK	TAKEDA PHARMACEUTICAL CO LTD	Japan	$41.48B	1,569,013,464	4.94%	0.00%
BTCY	BIOTRICITY INC	United States	$9.81M	9,258,957	3.86%	59.75%
TELO	TELOMIR PHARMACEUTICALS INC	United States	$182.99M	29,609,814	0.27%	16.90%	Net Buying
PTN	PALATIN TECHNOLOGIES INC	United States	$32.27M	16,136,640	6.00%	94.00%	Net Selling	Net Selling
MODD	MODULAR MEDICAL INC	United States	$38.76M	21,899,058	47.59%	38.11%	Net Buying
NLSP	NLS PHARMACEUTICS LTD	Switzerland	$5.85M	35,671,780	22.87%	0.00%
IINN	INSPIRA TECHNOLOGIES OXY BHN LTD	Israel	$36.00M	15,652,176	0.59%	0.00%
SCNI	SCINAI IMMUNOTHERAPEUTICS LTD	Israel	$2.51M	1,857,169,984	0.02%	0.04%
FGEN	FIBROGEN INC	United States	$119.37M	99,475,398	61.64%	12.55%	Net Selling	Net Selling
CCEL	CRYO CELL INTERNATIONAL INC	United States	$72.94M	8,104,477	8.74%	91.26%
EUDA	EUDA HEALTH HOLDINGS LTD	Singapore	$57.38M	24,627,509	3.87%	39.80%
ATNF	180 LIFE SCIENCES CORP	United States	$1.49M	941,590	0.26%	99.74%	Net Buying
MD	PEDIATRIX MEDICAL GROUP INC	United States	$651.30M	84,147,224	95.32%	4.68%	Net Selling	Net Selling
HUMA	HUMACYTE INC	United States	$753.80M	119,084,353	19.49%	36.46%	Net Selling	Net Buying
ABVC	ABVC BIOPHARMA INC	United States	$11.61M	10,851,823	1.20%	98.80%
CYH	COMMUNITY HEALTH SYSTEMS INC	United States	$501.67M	138,966,388	61.56%	38.44%	Net Buying	Net Selling
NBY	NOVABAY PHARMACEUTICALS INC	United States	$4.50M	37,831,410	0.67%	99.33%
ASLN	ASLAN PHARMACEUTICALS LTD	Singapore	$8.29M	466,761,105	0.64%	0.00%
NVAX	NOVAVAX INC	United States	$1.83B	140,403,554	54.59%	19.52%	Net Selling	Net Selling
BHC	BAUSCH HEALTH COMPANIES INC	Canada	$2.48B	366,796,721	68.76%	30.58%	Net Selling	Net Selling
MPLN	MULTIPLAN CORP	United States	$379.83M	644,868,398	74.70%	25.30%	Net Buying	Net Buying
IRWD	IRONWOOD PHARMACEUTICALS INC	United States	$1.03B	158,957,123	72.93%	27.07%	Net Selling	Net Buying
TBRG	TRUBRIDGE INC	United States	$133.71M	15,007,262	67.41%	32.59%	Net Buying	Net Buying
AKAN	AKANDA CORP	United Kingdom	$1.53M	8,842,851	1.20%	0.00%
TLSI	TRISALUS LIFE SCIENCES INC	United States	$267.52M	27,159,327	3.41%	73.15%	Net Selling

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	679	-0.70%	+1.84%	+3.96%	-19.69%	8.47x	6.01x	+18.62%	+3.83%	-27.52%	+77.73%	Strong Buy
Diagnostics & Research	64	-0.44%	+1.56%	+12.99%	+11.25%	38.96x	4.47x	-13.18%	+6.48%	+11.49%	+5.02%	Buy
Drug Manufacturers - General	18	-0.03%	+1.66%	+7.51%	+18.11%	31.85x	6.42x	+33.60%	+8.10%	+14.22%	+11.01%	Buy
Drug Manufacturers - Specialty & Generic	87	-0.75%	+1.10%	+5.60%	-1.99%	-1.01x	2.20x	+12.36%	+3.36%	+6.05%	+32.29%	Strong Buy
Healthcare Plans	12	+0.52%	+1.22%	+4.66%	+4.46%	25.53x	3.07x	+15.18%	+4.74%	+11.78%	+11.78%	Buy
Health Information Services	61	+0.25%	+2.04%	-0.03%	-19.66%	9.15x	3.33x	+6.71%	+2.23%	+5.33%	+26.88%	Buy
Medical Care Facilities	51	-0.09%	+0.01%	+4.96%	+11.10%	39.23x	4.59x	-92.23%	+6.58%	+13.66%	+15.22%	Buy
Medical Devices	150	-0.35%	+1.37%	+2.08%	-13.46%	30.60x	4.00x	+7.35%	+5.26%	+8.26%	+19.86%	Buy
Medical Distribution	10	+0.87%	+0.34%	+1.16%	+26.37%	26.84x	107.17x	-11.87%	+3.44%	+19.58%	+10.98%	Buy
Medical Instruments & Supplies	56	+0.16%	+1.85%	+6.62%	-5.76%	59.83x	3.64x	+11.25%	+7.73%	+10.05%	+18.23%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 46 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -42.43% over the past year, underperforming other healthcare stocks by -37 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 33.84% from Cross Country Healthcare's current stock price of $14.57.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the second best healthcare stock with a Zen Score of 67, which is 43 points higher than the healthcare sector average of 24. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 14.93% over the past year, overperforming other healthcare stocks by 21 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 44.77% from Corcept Therapeutics's current stock price of $28.09.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) is the third best healthcare stock with a Zen Score of 65, which is 41 points higher than the healthcare sector average of 24. It passed 20 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 12.82% over the past year, overperforming other healthcare stocks by 19 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 104.84% from Kamada's current stock price of $5.37.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Sanofi (NASDAQ:SNY)

Sanofi (NASDAQ:SNY) has an annual dividend yield of 8.1%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Sanofi's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 82.1% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.93%, which is 6 percentage points higher than the healthcare sector average of 2.05%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 7.88%, which is 6 percentage points higher than the healthcare sector average of 2.05%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.28% in the last day, and up 1.47% over the last week. Heart Test Laboratories was the among the top losers in the healthcare sector, dropping -38.37% yesterday.

Heart Test Laboratories shares are trading lower after the company's 1-for-100 reverse stock split began trading on a split-adjusted basis.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -44.03% in the past year. It has underperformed other stocks in the healthcare sector by -38 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -23.81% in the past year. It has underperformed other stocks in the healthcare sector by -18 percentage points.

3. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Cross Country Healthcare has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Cross Country Healthcare's stock has dropped -42.43% in the past year. It has underperformed other stocks in the healthcare sector by -37 percentage points.

Are healthcare stocks a good buy now?

50.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 32.6% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.